靶点针对疾病信息18(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
标题
内容
TARGETID
T86591
TARGNAME
Peroxisome proliferator-activated receptor alpha (PPARA)
INDICATI
Approved Hyperlipidemia [ICD-11: 5C80]
INDICATI
Approved Hyper-lipoproteinaemia [ICD-11: 5C80]
INDICATI
Approved Inborn lipid metabolism error [ICD-11: 5C52]
INDICATI
Approved Type 2 diabetes mellitus [ICD-11: 5A11]
INDICATI
Phase 3 Diabetes mellitus [ICD-11: 5A10]
INDICATI
Phase 2 Acute diabete complication [ICD-11: 5A2Y]
INDICATI
Phase 2 Dyslipidemia [ICD-11: 5C80-5C81]
INDICATI
Phase 1 Gout [ICD-11: FA25]
INDICATI
Discontinued in Phase 2 Heart failure [ICD-11: BD10-BD1Z]
INDICATI
Preclinical Idiopathic interstitial pneumonitis [ICD-11: CB03]
INDICATI
Preclinical Metabolic disorder [ICD-11: 5C50-5D2Z]
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3